VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q2 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q1 2023 | $21 | -61.1% | 3,142 | -42.7% | 0.00% | – |
| Q4 2022 | $54 | -99.9% | 5,483 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | -10.0% | 5,483 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -51.2% | 5,483 | -49.6% | 0.00% | – |
| Q1 2022 | $123,000 | -62.7% | 10,872 | -48.4% | 0.00% | -100.0% |
| Q4 2021 | $330,000 | -8.6% | 21,060 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $361,000 | -60.2% | 21,060 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $906,000 | +43.4% | 42,120 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $632,000 | -43.4% | 42,120 | +172.6% | 0.00% | – |
| Q4 2020 | $1,117,000 | +644.7% | 15,452 | 0.0% | 0.00% | – |
| Q3 2020 | $150,000 | -14.8% | 15,452 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $176,000 | – | 15,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |